Law
Offices of Howard G. Smith announces that it is investigating
potential claims on behalf of investors of Dr. Reddy's Laboratories,
Ltd. (“Dr. Reddy’s” or the “Company”) (NYSE: RDY) concerning the
Company’s and its officers’ possible violations of federal securities
laws. Law Offices of Howard G. Smith is preparing a lawsuit to recover
damages on behalf of injured Dr. Reddy’s investors.
On November 6, 2015, Dr. Reddy's reported that the Company received a
"warning letter" from the United States Food and Drug Administration
(“FDA”) over inadequate quality controls at three manufacturing plants
producing drugs for cancer and other diseases. The Company further
disclosed that it was undertaking an initiative to revamp the Company’s
quality controls. On this news shares of Dr. Reddy’s fell sharply
thereby damaging investors.
If you purchased Dr. Reddy’s securities, have information or would like
to learn more about these claims, or have any questions concerning this
announcement or your rights or interests with respect to these matters,
please contact Howard G. Smith, Esquire, of Law Offices of Howard G.
Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by
telephone at 215-638-4847, toll-free at 888-638-4847, or by email to howardsmith@howardsmithlaw.com,
or visit our website at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151109006473/en/
Copyright Business Wire 2015